Key facts
- Notable investors include Queen's Park Equity.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Initiate Consultancy
- ·The full record, as it builds
Funding rounds
No funding rounds for Initiate Consultancy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Initiate Consultancy
Provider of health economics and market access consultancy services intended to serve pharmaceutical, medical technology, and medical device companies. The company offers health technology assessment strategy and submissions, health economic modelling, pricing and reimbursement planning, value communication support, launch preparation activities, and asset evaluation services, thereby enabling clients to assess product value, plan market entry, and support access decision processes.
- Sector
- Business Products and Services (B2B)
- HQ
- Alderton, United Kingdom
- Founded
- 2019
- Employees
- 40
- Website
- initiateconsultancy.com/
- Ownership
- Privately Held (backing)
Initiate Consultancy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Initiate Consultancy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Initiate Consultancy in its N-PORT filings yet. We sweep new filings monthly.